Jones Financial Companies
PRME icon

Jones Financial Companies’s Prime Medicine PRME Stock Holding History

Jones Financial Companies’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Sell
40,307
-96
-0.2% -$365 ﹤0.01% 2544
2025
Q4 		$140K Buy
40,403
+30,828
+322% +$137K ﹤0.01% 2078
2025
Q3 		$49K Buy
+9,575
New +$38.9K ﹤0.01% 2389

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Jones Financial Companies's PRME Position: Q1 2026 in Review

Jones Financial Companies reduced its Prime Medicine (PRME) stake by 0.24% in Q1 2026, selling an estimated $365 and leaving 40,307 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

Jones Financial Companies first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. The position peaked at $140K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Jones Financial Companies held 40,307 shares of Prime Medicine worth $136K as of Q1 2026.
  • Jones Financial Companies sold 96 Prime Medicine shares in Q1 2026, an estimated $365.
  • Prime Medicine made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2544 holding.
  • Jones Financial Companies first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Prime Medicine position peaked at $140K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.